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Background: Anxiety and depression are common co-morbidities in patients with chronic obstructive pulmonary
disease (COPD). Serious implications can result from psychological difficulties in COPD including reduced survival,
lower quality of life, and reduced physical and social functioning, increased use of health care resources and are
associated with unhealthy behaviours such as smoking. Cognitive behavioural therapy (CBT) is a psychological interven-
tion which is recommended for the treatment of many mental health problems including anxiety and depression.
Unfortunately access to trained CBT therapists is limited. The aim of this study is to test the hypothesis that CBT deliv-
ered by respiratory nurses is effective in the COPD population. In this paper the design of the Newcastle Chronic
Obstructive Pulmonary Disease Cognitive Behavioural Therapy Study (Newcastle COPD CBT Care Study) is described.
Methods/Design: This is a prospective open randomised controlled trial comparing CBT with self-help leaflets. The
primary outcome measure is the Hospital Anxiety & Depression Scale (HADS) – anxiety subscale. Secondary outcome
measures include disease specific quality of life COPD Assessment Tool (CAT), generic quality of life (EQ5D) and HADS-
depression subscale. Patients will be followed up at three, six and 12 months following randomisation.
Discussion: This is the first randomised controlled trial to evaluate the use of cognitive behavioural therapy undertaken
by respiratory nurses. Recruitment has commenced and should be complete by February 2014.
Trial registration: Current Controlled Trials, ISRCTN55206395
Keywords: Anxiety, Chronic obstructive pulmonary disease (COPD), Cognitive behavioural therapy (CBT), Depression,
Respiratory nursesBackground
COPD is an umbrella term used to describe chronic
bronchitis and emphysema which cause irreversible ob-
struction of the airways. COPD is increasingly felt to be
a systemic syndrome with multiple co morbidities. Anx-
iety and depression are amongst the most common co-
morbidities in COPD. Cognitive behavioural therapy* Correspondence: karen.heslop@nuth.nhs.uk
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reproduction in any medium, provided the or(CBT) is a psychological intervention which is recom-
mended for the treatment of many mental health prob-
lems including anxiety and depression. A breathing test
called spirometry measures how much air can be ex-
haled in 1 second (FEV1) and the forced vital capacity
(how much air can be exhaled fully after a full inhal-
ation). The severity of obstruction is defined as, mild
(FEV1 > 80% predicted), moderate (FEV1 50-79%), severe
(FEV1 30-49%) and very severe [1]. The main cause of
COPD is smoking [2].
Symptoms of COPD are cough, sputum production,
wheeze and breathlessness. Symptoms of COPD lead toLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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consequence day to day functioning is affected and qual-
ity of life is reduced [3,4]. Patients focus on feeling un-
well, their inability to perform everyday activities, and
on the emotional consequences of the disease [5]. People
with COPD are two to three times more likely to experi-
ence mental health problems than the general popula-
tion [6]. Serious implications for people with COPD and
mental health problems include poorer clinical out-
comes, lower quality of life, reduced ability to manage
physical symptoms effectively and are associated with
unhealthy behaviours such as smoking [6] and reduced
survival [3].
A systematic review and meta-analysis reported the
prevalence of clinically significant anxiety at 36% and
40% for depression in patients with COPD [7]. Anxiety
is an unpleasant emotional state associated with fear and
distressing physical symptoms including rapid breathing
and shortness of breath [8]. These symptoms overlap
with the symptoms of COPD [9]. Anxiety is a significant
predictor of the frequency of hospital admissions and re-
admissions for acute exacerbations of COPD [10].
Panic disorder is up to ten times more prevalent in pa-
tients with COPD than in the general population [11,12]
Panic disorder consists of recurring, unforeseen panic
attacks. This is followed by persistent worry about hav-
ing further attacks. Panic attacks develop suddenly, are
associated with intense fear, anxiety, and physical arousal
and are relatively short lived [8]. In patients with COPD,
worsening breathlessness is often interpreted in a cata-
strophic way. Patients commonly think they cannot
breathe and death is imminent. Symptoms of increased
physical arousal follow leading to an escalating cycle
which results in panic [13]. Patients become anxious
about becoming breathless and avoid exertion which
may trigger unpleasant symptoms occurring. This leads
to physical de-conditioning thereby compounding exer-
tional breathlessness, reducing confidence, which col-
lectively exacerbates the panic cycle.
Management of psychological problems in COPD re-
mains poor [14]. Guidelines for the management of anx-
iety and depression [15,16] recommend psychological
treatment, pharmacological treatment or both in com-
bination. Psychological interventions include CBT, coun-
selling and self-help approaches. There are a growing
number of studies evaluating the efficacy of psycho-
logical interventions to improve the psychological well-
being of patients with COPD. Most of the published
studies have used cognitive behavioural therapy. There is
some evidence in a systematic review that psychological
interventions such as cognitive behavioural therapy im-
pact on anxiety [14]. However, a meta-analysis revealed
that most studies were under-powered and demon-
strated a small effect for anxiety only [14]. There is aneed for high-quality systematic research of CBT in the
routine management of patients with COPD.
A brief cognitive behavioural treatment intervention
has been developed specifically for patients with COPD.
The Lung Manual Treatment Program is based on prin-
ciples of CBT and self-management [17]. The interven-
tion is undertaken by respiratory nurses and aims to
reduce anxiety, depression, improve quality of life and
have health economic benefits. A randomised controlled
trial has been developed to evaluate the efficacy of a
brief CBT intervention undertaken by respiratory nurses
in this patient group. The design and methods of the
study are now presented.
Methods/Design
Design
The Newcastle COPD CBT CARE study is a prospective
two armed randomised controlled trial (RCT) with lon-
gitudinal follow up of 12 months. The main aim of the
trial is to identify if respiratory nurse delivered CBT, re-
duces symptoms of anxiety in patients with COPD. Data
will be collected three, six and 12 months following
randomization. Data collected at each time point can be
found in Table 1.
Primary outcome
The primary objective is to investigate if CBT delivered
by respiratory nurses with either advanced CBT training
(Post Graduate Diploma) or basic training in CBT tech-
niques, reduces anxiety. The HADS Hospital Anxiety &
Depression Scale (HADS) will be used to measure anx-
iety. Patients will be followed up at three, six and twelve
months following randomisation into the study. The ef-
fects of the CBT intervention will be compared to usual
care. A standardised manualised brief CBT intervention
will be used. 224 patients will be required to complete
the primary outcome at three months (112 in each arm).
Patients will be stratified according to severity of COPD
and age at randomisation.
Secondary outcomes
Six questions have been developed as secondary out-
comes. Firstly, does CBT delivered by respiratory nurses
reduce hospital admissions in the 12 months following
randomisation? Secondly, does CBT delivered by re-
spiratory nurses reduce anxiety at six and 12 months
compared to standard care? Thirdly, identify if CBT
more effectively delivered by basic (three day short
course) CBT trained respiratory nurses or advanced
(postgraduate diploma in CBT) CBT trained respiratory
nurses? Fourth, if CBT delivered by respiratory nurses
reduce depression as measured by Hospital Anxiety and
Depression Scale – Depression (HADS-D) at three, six
and 12 months compared to standard care? Fifth, does
Table 1 Outcome measures and time of assessment in Newcastle COPD CBT CARE study
Baseline Follow up
visit 1– 12–14 weeks
Follow up
visit 2–6 months
Follow up
visit 3–12 months
Demographic Data √ - - -
Gender √ - - -
Age √ - - -
Smoking Status & pack years √ - - √
Ethnic Group √ - - -
Marital Status √ - - √
Education √ - - -
Inhaler Technique √ - - -
HAD - A √ √ √ √
HAD - D √ √ √ √
CAT √ √ √ √
EQ5D √ √ √ √
Spirometry √ - - -
Oxygen saturations √ - - -
MRC Dyspnoea Score √ - - -
Co-morbidities √ √ √ √
BMI √ √ √ √
Medication √ √ √ √
Health care utilisation (primary & secondary care) √ - - √
Participation in pulmonary rehabilitation √ √ √ √
√ refers to data collected at each visit.
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quality of life at three, six & 12 months as measured by
a reduction in COPD Assessment Tool (CAT) and Euro-
Qol 5 Dimension questionnaire (EQ5D) scores? Finally,
can this study inform design of a multicentre RCT?Setting
The setting for this study is an urban population in the
North East of England. Patients who attend the respira-
tory clinics at Newcastle upon Tyne Hospitals NHS
Foundation Trust with a diagnosis of COPD are rou-
tinely asked to complete a HADS questionnaire. All pa-
tients with a confirmed diagnosis of COPD with an
FEV1/FVC ratio <0.7 who have a HADS score of ≥8 are
offered information about the study. The unit already
runs a respiratory nurse led CBT service, supervised and
supported by a Consultant Clinical Psychologist (CB).
Patients are offered between two and six individualised
CBT appointments.Research governance
Approvals for this study were obtained from Sunderland
Regional Ethics Committee. The trial has been entered
onto the U.K. NIHR Clinical Research Network (CRN)
Portfolio (Reference UKCRN Study ID: 10519; http://public.ukcrn.org.uk/search/StudyDetail.aspx?StudyID=10519 and
ISRCTN study 55206395).
Inclusion criteria
 Patient with a confirmed diagnosis of COPD (FEV1/
FVC ratio <70% [5].
 All levels of COPD disease severity will be eligible
including mild to moderate (FEV1 >50% predicted)
and severe to very severe (FEV1 <50% predicted).
 Patients with HADS –anxiety subscale scores of ≥8.
 Willing to participate in the study and provide
written consent.
 Agree to attend a minimum of two and maximum
of six CBT sessions.
Exclusion criteria
 Patients with a HADS-A score <8.
 Patients with known psychiatric history such as
psychosis.
 Patients currently receiving psychological talking
therapy including CBT treatment.
 Patients with cognitive impairment (e.g. dementia).
 Patients involved in any other interventional clinical
trial.
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Patients enrolled in the study are randomised on a 1:1:
basis to CBT or control using a computer generated
software package after signing the consent form. Patients
are stratified at randomisation for COPD disease severity
using NICE 2010 categories (mild to moderate and severe
to very severe) and age. Patient initials, date of birth and
severity of COPD are entered into the web-based system,
which returns the allocation status. Patients are informed
of their treatment group following randomisation.
Standard care
Both groups receive standard medical care which in-
volves recording spirometry, oxygen saturation levels
and HADS questionnaire at each routine medical clinic
visit. Patients randomised to standard care arm of this
study are provided with written information on anxiety
and/or depression (Northumberland, Tyne & Wear
Mental Health Trust leaflets). Patients are advised to
contact their primary care team should further help be
required. Treatment in primary care will be directed by
primary care team and is not part of the trial intervention.
It may include psychotherapy, counselling, antidepressants
and/or anxiolytics. Information on primary care directed
interventions will be recorded at each study follow up
visit.
CBT intervention
The study intervention involves standard care plus a
brief CBT based program delivered by respiratory
nurses. Clear manualised treatment will be used to en-
sure the CBT based treatment can be replicated. A man-
ualised protocol has been specifically developed for this
study by the Respiratory Nurse (KH) & Consultant
Psychologist (CB). The CBT will be delivered by four re-
spiratory nurses (two trained to Post Graduate Diploma
Level and two who have completed a three day training
course at foundation level). Monthly clinical supervision
will be provided for all four nurses by a Consultant Clin-
ical Psychologist (CB). The intervention will be delivered
to individual patients in either in a respiratory clinic in
secondary care or within the patients’ home. The CBT
intervention is tailored to the patient’s individual needs
(within the boundaries of the manual). Patients will be
offered between two – six sessions of therapy as re-
quired. The number of sessions will be based on the pa-
tient’s progress and HADS scores. The first session will
take 30–60 minutes. Subsequent follow up sessions will
take up to 30 minutes.
The intervention includes the following processes. The
nurse assesses the patient’s reported current difficulties
and develops an individualised treatment plan. The
treatment plan may include the development of coping
strategies including goal-setting, identifying, challengingand changing negative thoughts, distraction, breathing
control, problem-solving, activity scheduling/diary, re-
laxation, weighing up pros and cons; positive logs, learn-
ing to respond appropriately to symptoms and reducing
avoidance and safety behaviours that maintain anxiety
and low mood.
Quality control of manualised CBT program
Quality control will be maintained through adherence to
the study protocol, the principles of good clinical prac-
tice, research governance and clinical trial regulations.
Data is being collected to assess consistency of interven-
tion delivered in the treatment arm across nurses and
principles of delivery of CBT. Sixty (5%) of the CBT ses-
sions will be video recorded to validate adherence to the
CBT manual and the quality of the CBT intervention.
The assessment is undertaken by a CBT therapist inde-
pendent of the study delivery team with feedback given
as needed.
Process evaluation
A process evaluation will be carried out as described by
previous research [18].
The following outcomes assessed: The proportion of
the population of the intended target population that ac-
tually participated in the intervention, the number of pa-
tients who completed the intervention, the mean number
of CBT sessions and patient satisfaction of the interven-
tion and patient information leaflets.
Sample size
Complete outcome data is expected to be available on
112 patients per group (224 in total). This gives 80%
power to detect a standardised difference of 0.375
(equivalent to a change in HADS-A of at least 1.5 when
standard deviation is assumed at 4) assuming a type 1
error rate of 5%.
Analysis
An “Intention to treat” analysis is planned. Descriptive
statistics will be used for analysis. The sample size calcu-
lation assumes that groups will be compared using an
independent t-test (the primary outcome variable being
the HADS-A score at three months). For data collected
at multiple points in time, a longitudinal analysis will be
undertaken. This will involve comparing the way HAD
scores change over time in the different trial arms using
repeated measures analysis of variance such as a mixed
effects or multilevel model (repeat assessments nested
within patients). This will make use of all the observed
data for a patient even if they missed one or more time
points. Finally the effect of missing data on our results
will be estimated.
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An economic evaluation will be undertaken. Costs of re-
spiratory admissions, cost of CBT intervention, cost of
attending clinic, QALY’s (Quality of adjusted life year
saved as per EQ5D) will be assessed.
Trial steering committee
A trial steering committee has been formed to advise and
monitor the study. The steering committee includes a pa-
tient and carer with COPD and a representative from the
British Lung Foundation Charity. The committee has a
number of experts and patient representatives including:
 Consultant Chest Physician (Chair).
 Representative for the British Lung Foundation and
advisor for service users.
 A carer & service user.
 An expert in trial design.
 Respiratory Nurse Consultant & CBT therapist
(Trial management/.Recruitment/Consent/Cognitive
Behavioural Therapy & training respiratory nurses).
 A Chest Physician & academic researcher.
 Head of Nursing and Midwifery Research, an expert
in research ethics and governance.
 A Clinical Psychologist will advise the project team
particularly in respect of development of manualised
training and provide clinical supervision.
 Medical statistician.
There will be overall oversight by a Trials Steering
Committee (TSC) that will meet three times a year. As
CBT is frequently undertaken within clinical care it is
envisaged that this study poses minimum safety risks
therefore a decision has been made not to have a separ-
ate study management group. However, recruitment,
quality of data and safety of participants will be reviewed
at each trial steering committee.
Discussion
This study design has evolved through literature review,
contact with published authors, a case series defining
local COPD anxiety & depression rates [19] and a non-
randomised case series of CBT in COPD [17]. Further
study design refinement was through the National Insti-
tute of Health Research Design Service. This research
builds upon and extends the prior work [15,16,20-24].
The study will address impact, feasibility and efficacy of
teaching CBT skills to non-mental health professionals
(such as respiratory nurses), to treat anxiety and depres-
sion in a clinical population of COPD patients. This is
particularly important as there is a national shortage of
CBT therapists. In routine clinical practice, CBT delivery
by respiratory nurses could be the most realistic and po-
tentially cost effective model to provide psychologicalcare for patients with COPD. Respiratory nurses are
front line staff who work with high volumes of COPD
patients and will have the skill sets that may allow dis-
tinction between organic and psychological causes of
breathlessness. The ability to integrate aspects of COPD
care within one (familiar) setting such as a respiratory
clinic or with familiar staff may help reduce barriers to
engagement with the mental health aspects of COPD.
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